On April 3, the National Medical Products Administration held a Special Teleconference on Fully Strengthening Supervision over Export Quality of Medical Devices for Epidemic Prevention and Control, aiming at re-emphasizing, re-deploying and re-implementing efforts in the whole system to fully strengthen supervision over export quality of medical devices for epidemic prevention and control. It was stressed at the conference that the whole system shall further improve the political position, comprehensively strengthen supervision over export quality of medical devices for epidemic prevention and control, and effectively guarantee the quality and safety of exported medical devices. Xu Jinghe, Deputy Director of NMPA, attended the conference and made a speech.

Xu Jinghe pointed out that ensuring the quality of medical devices for epidemic prevention and control bears on national image and international reputation. Every effort shall be made to ensure the quality and safety of exported medical device products.

The conference made clear the following requirements: first of all, enterprise situations shall be quickly found out to ensure focus on key points in supervision. Secondly, specially-assigned persons are responsible for reporting to ensure the quality of disclosed information. Thirdly, the legal position shall be clearly grasped, and the export sales certificate shall be standardized. Fourthly, a capable team shall be organized in the system to intensify supervision and inspection. Fifthly, the supervision of export products shall be highlighted, and sampling inspection for supervision shall be intensified.

The conference emphasized that for any violations of laws and regulations found in the supervision, the “Four Strictest” requirements shall be implemented and the main responsibility of enterprises , as well as the responsibility of territorial management, shall be strictly implemented.

As is reported, the NMPA, together with relevant departments and bureaus of the State Administration for Market Regulation, will jointly set up a task force to carry out special supervision in some regions with a large export volume of medical devices for epidemic prevention and control and include the quality supervision of the medical devices for epidemic prevention and control that have been exported in the annual appraisal.

At the conference, the relevant persons in charge of Jiangsu Drug Administration, Zhejiang Medical Products Administration, Shandong Medical Products Administration, and Guangdong Medical Products Administration delivered speeches regarding comprehensively enhancing the quality supervision of exported medical devices for epidemic prevention and control. Responsible persons and related personnel of competent departments and bureaus and institutions directly under the NMPA, relevant persons in charge of medical products administrations in all provinces (cities and districts) and Xinjiang Production and Construction Corps, and responsible persons and relevant personnel of competent departments and directly affiliated institutions attended the conference.

For original text and document, please refer to original Chinese website